SCHEMBL12798987

SCHEMBL12798987

Cc1ccc(NC(=O)C(C)n2nc(C)ccc2=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.54
LMNA P02545 5/20 0.53
ALDH1A1 P00352 2/20 0.53
HTT P42858 1/20 0.53
MAPT P10636 3/20 0.49
POLB P06746 2/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALOX12 P18054 1/20 0.46
CYP2C19 P33261 1/20 0.46
FPR1 P21462 6/20 0.45
NPSR1 Q6W5P4 1/20 0.43
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21245458 0.73 TP53 (0.49) TP53ALDH1A1HTTMAPTPOLB
SCHEMBL21245460 0.72 TP53 (0.48) TP53LMNAALDH1A1HTTMAPT
SCHEMBL20150735 0.71 LMNA (0.46) LMNAALDH1A1HTTMAPTPOLB
SCHEMBL20150739 0.70 LMNA (0.44) TP53LMNAALDH1A1HTTMAPT
SCHEMBL178429 0.69 MAPT (0.71) TP53LMNAALDH1A1HTTMAPT
SCHEMBL20113814 0.69 TP53 (0.73) TP53LMNAHTTMAPTPOLB
SCHEMBL30729658 0.68 MAPT (0.69) LMNAALDH1A1HTTMAPTPOLB
SCHEMBL10975281 0.67 MAPT (0.67) LMNAALDH1A1HTTMAPTPOLB
SCHEMBL20150736 0.67 MAPT (0.67) TP53LMNAALDH1A1HTTMAPT
SCHEMBL12997450 0.67 MAPT (0.67) LMNAALDH1A1HTTMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011043942-A1 COMBINATION THERAPY USING A BETA 3 ADRENERGIC RECEPTOR AGONIST AND AN ANTIMUSCARINIC AGENT MERCK SHARP & DOHME CORP. (US) 2011-04-14 WO disclosed